#checkpoint-inhibitors — Wednesday, July 15, 2026 (1 items)
| 0 | 💬 0 |
Perioperative tislelizumab plus chemotherapy for locally advanced gastric cancer: A randomized, prospective phase 2 trial.
(linkinghub.elsevier.com)
|
Cancer Cell 2026-07-15 | #immunotherapy #gastric cancer #biomarker #neoadjuvant #checkpoint-inhibitors |